Zoetis Announces Launch of Solensia for Treatment of OA in Cats

¬†Zoetis Inc. (NYSE:ZTS) announced September 26 that Solensia (frunevetmab injection) is now available to veterinary clinics across the U.S. As a leading company in pet pain management, Zoetis is dedicated to understanding the science of pet pain, and Solensia is an example of how the company is using that knowledge to provide innovative treatments to … Continue reading Zoetis Announces Launch of Solensia for Treatment of OA in Cats